Effect of insulin in combination with selenium on IRS/PI3K-mediated GLUT4 expression in cardiac muscle of diabetic rats

European Review for Medical and Pharmacological Sciences

Volumn 15, Issue 12, 2011, Pages 1452-1460

  Xu, T J ^a   Liu, Y ^b   Yuan, B ^c  

^a XI'AN MEDICAL UNIVERSITY   (China)

^b Bureau Group Co LTD   (China)

^c MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

GLUT4; Insulin; IRS 1; PI3K; Sodium selenite; STZ diabetic rats

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER 4; HEMOGLOBIN A1C; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; PHOSPHATIDYLINOSITOL 3 KINASE; SODIUM SELENITE; ANTIDIABETIC AGENT; INSULIN RECEPTOR SUBSTRATE; IRS1 PROTEIN, RAT; SLC2A4 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; CONTROLLED STUDY; DIABETES CONTROL; DRUG EFFICACY; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; GLYCEMIC CONTROL; HEART MUSCLE; HEMOGLOBIN BLOOD LEVEL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LOW DRUG DOSE; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REVIEW; STREPTOZOCIN DIABETES; TREATMENT DURATION; ANIMAL; ARTICLE; DRUG COMBINATION; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DRUG THERAPY, COMBINATION; GLUCOSE TRANSPORTER TYPE 4; HYPOGLYCEMIC AGENTS; IMMUNOBLOTTING; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; MALE; MYOCARDIUM; PHOSPHATIDYLINOSITOL 3-KINASES; RATS; RATS, SPRAGUE-DAWLEY; SODIUM SELENITE;

EID: 84857029307     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. AMERICAN DIABETES ASSOCIATION. Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes Care 1998; 21: 296-309.
2. CAI L, KANG YJ. Oxidative stress and diabetic car-diomyopathy: a brief review. Cardiovasc Toxicol 2001; 1: 181-193. (Pubitemid 37013746)
3. CULLEN P, VON ECKARDSTEIN A, SOURIS S, SCHULTE H, ASSMANN G. Dyslipidaemia and cardiovascular risk in diabetes. Diabetes Obes Metab 1999; 1: 189-198.
4. BIONDI-ZOCCAI GG, ABBATE A, LIUZZO G, BIASUCCI LM. Atherothrombosis, inflammation, and diabetes. J Am Coll Cardiol 2003; 41: 1071-1077. (Pubitemid 36384890)
5. WOJCIECHOWSKA-DURCZY SKA K, LEWI SKI A. Phospho-inositide 3-kinase alterations in the thyroid gland-a review study. Arch Med Sci 2009; 5: 10-15.
6. EGERT S, NGUYEN N, BROSIUS FC, SCHWAIGER M. Effects of wortmannin on insulin-and ischemia-induced stimulation of GLUT4 translocation and FDG up take in perfused rat hearts [J]. Cardio-vasc Res 1997; 35: 283-293. (Pubitemid 27372040)
7. DEBOSCH BJ, MUSLIN AJ. Insulin signaling pathways and cardiac growth. J Mol Cell Cardiol 2008; 44: 855-864.
8. JALALI S, AGHASI M, YEGANEH B, MESAELI N. Calreti-culin regulates insulin receptor expression and its downstream PI3 Kinase/Akt signalling pathway. Biochim Biophys Acta 2008; 1783: 2344-2351.
9. VISHNU PRASAD CN, ANJANA T, BANERJI A, GOPALAKRISH-NAPILLAI A. Gallic acid induces GLUT4 translocation and glucose uptake activity in 3T3-L1 cells. FEBS Lett 2010; 584: 531-536.
10. GARVEY WT, HARDIN D, JUHASZOVA M, DOMINGUEZ JH. Effects of diabetes on myocardial glucose transport system in rats: implications for diabetic cardiomyopathy. Am J Physiol 1993; 264: 837-844.
11. GUO Z, XIA Z, YUEN VG, MCNEILL JH. Cardiac expression of adiponectin and its receptors in strep-tozotocin-induced diabetic rats. Metab Clin Exp 2007; 56: 1363-1371. (Pubitemid 47404598)
12. LUO J, SOBKIW CL, HIRSHMAN M F, LOGSDON MN, LI TQ, GOODYEAR LJ, CANTLEY LC. Loss of class IA PI3K signaling in muscle leads to impaired muscle growth, insulin response, and hyperlipidemia. Cell Metab 2006; 3: 355-366.
13. NAVARRO-ALARCON M, LOPEZ-G DE LA SERRANA H, PEREZ-VALERO V, LOPEZ-MARTINEZ C. Serum and urine selenium concentrations as indicators of body status in patients with diabetes mellitus. Sci Total Environ 1999; 228: 79-85. (Pubitemid 29179532)
14. KARPEN CW, PRITCHARD AK, ARNOLD JH, CORNWELL DG, PANGAMALA RV. Restoration of prostacy-clin/thromboxane A2 balance in the diabetic rat. Diabetes 1982; 31: 947-951.
15. SALONEN JT, SALONEN R, SEPPANEN KANTOLA M, PARIAINEN M, ALFTHAN G, MAENPAA PH, TASKINEN E, RAU-RAMAA R. Relationship of serum selenium and an-tioxidants to plasma lipoproteins, platelet aggre-gability and prevalent ischemic heart disease in Eastern Finnish men. Atherosclerosis 1988; 70: 155-160. (Pubitemid 18091712)
16. SHENG XQ, HUANG KX, XU HB. Influence of alloxan-induced diabetes and selenite treatment on blood glucose and glutathione levels in mice. J Trace El-em Med Biol 2005; 18: 261-267.
17. NAVAS-ACIEN A, BLEYS J, GUALLAR E. Selenium intake and cardiovascular risk-what is new. Curr Opin Lipidol 2008; 19: 43-49.
18. RAYMAN M P. Selenoproteins and human health: insights from epidemiological data. Biochim Bio-phys Acta 2009; 1790: 1533-1540.
19. LACLAUSTRA M, NAVAS-ACIEN A, STRANGES S, ORDOVAS JM, GUALLAR E. Serum selenium levels and hypertension in the US population. Circ Cardiovasc Qual Outcomes 2009; 2: 369-376.
20. YUNTANG W, ZHONG S, SUPING C, HONG C. Effects of zinc and selenium on the disorders of blood glu cose and lipid metabolism and its molecular mechanism in diabetic rats. J Hygiene Res 2004; 33: 70-73.
21. YUNTANG W, SUPING C, ZHONG S, HONG C, YONG-MING W. Regulation of zinc, selenium, chromium on disorders of blood glucose and lipid metabolism in diabetic rats. Chinese J Public Health Sep 2004; 20: 1083-1088.
22. ZHANG PING,LIANG ZI-WEN,WANG HAI-HUI,CAI HONG-WEI, ZHANG SU-HUA, WANG NOU-PING. Effect of sodium vanadate on GLUT4 translocation in cardiac tissue of streptozotocin-induced diabetic rats. Ac-ta Acad Med Milit Tertlae 2004; 26: 1094-1097.
23. PILLAY TS, MAKGOBA MW. Enhancement of EGF and insulin-stimulated tyrosine phosphorylation of endogenous substrates by sodium selenate. FEBS Lett 1992; 302: 38-42.
24. BATTELL ML, DELGATTY HLM, MCNEIL JH. Sodium se-lenate corrects glucose tolerance and heart function in STZ diabetic rat. Mol Cell Biochem 1998; 179: 27-34. (Pubitemid 28118839)
25. BLEYS J, NAVAS-ACIEN A, GUALLAR E. Serum selenium levels and all-cause, cancer, and cardiovascular mortality among US adults. Arch Intern Med 2008; 168: 404-410. (Pubitemid 351347132)
26. BLEYS J, NAVAS-ACIEN A, LACLAUSTRA M, PASTOR-BARRIU-SO R, MENKE A, ORDOVAS JM, STRANGES S, GUALLAR E. Serum selenium and peripheral arterial disease: results from the national health and nutrition examination survey. Am J Epidemiol 2009; 169: 996-1003.
27. ORVIG C, THOMPSON KH, BATTELL M, MCNEILL JH. Vanadium compounds as insulin-mimics. Met Ions Biol Syst 1995; 31: 575-594.
28. INZUCCHI S. Classification and diagnosis of diabetes mellitus. In: Porte D, Sherwin R, Baron A. (Eds.), Elenberg & Rifkin's Diabetes Mellitus. Mc-GrawHill, NewYork, 2003; p. 274.
29. RAVIPATI G, ARONOW WS, KUMBAR S, KUMAR A, RAPERA-LLEVA R, MENGA G, WEISS MB, MCCLUNG JA. Patients with diabetes mellitus with ischemic stroke have a higher hemoglobin A1c level and a higher serum low-density lipoprotein cholesterol level than diabetics without ischemic stroke. Arch Med Sci 2009; 5: 391-393.
30. GORDON L, MORRISON EY, MCGROWDER DA, YOUNG R, GARWOOD D, ZAMORA E, ALEXANDER-LINDO RL, IRVING R, PEREZ SANZ EC. Changes in clinical and metabolic parameters after exercise therapy in patients with type 2 diabetes. Arch Med Sci 2008; 4: 427-437.
31. ABEL ED. Glucose transport in the heart. Front Biosci 2004; 9: 201-215.
32. BAUMANN CA, SALTIEL AR. Spatial compartmental-ization of signal transduction in insulin action. Bioessays 2001; 23: 215-222. (Pubitemid 32192140)
33. VIRKAMAKI A, UEKI K, KAHN CR. Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J Clin Invest 1999; 103: 931-943. (Pubitemid 29169600)
34. KOK K, GEERING B, VANHAESEBROECK B. Regulation of phosphoinositide 3-kinase expression in health and disease. Trends Biochem Sci 2009; 3: 115-127.
35. TOYODA T, AN D, WITCZAK CA, KOH HJ, HIRSHMAN M F, FUJII N, GOODYEAR LJ. Myo1c regulates glucose uptake in mouse skeletal muscle. J Biol Chem 2010; 12: 1-17.
36. KRAEGEN EW, SOWDEN JA, HALSTEAD MB, CLARK PW, RODNICK KJ, CHISHOLM DJ, JAMES DE. Glucose transporters and in vivo glucose uptake in skeletal and cardiac muscle: fasting, insulin cells. Bioessays 1994; 16: 753-759.
37. BELKE DD, BETUING S, TUTTLE MJ, GRAVELEAU C, YOUNG ME, PHAM M, ZHANG D, COOKSEY RC, MC-CLAIN DA, LITWIN SE, TAEGTMEYER H, SEVERSON D, KAHN CR, ABEL ED. Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. J Clin Invest 2002; 109: 629-639. (Pubitemid 34204842)
38. STAPLETON SR. Selenium: an insulin-mimetic. Cell Mol Life Sci 2000; 57: 1874-1879. (Pubitemid 32102583)
39. MUELLER AS, PALLAUF J. Compendium of the an-tidiabetic effects of supranutritional selenate doses. In vivo and in vitro investigations with type II diabetic db/db mice, J Nutr Biochem 2006; 17: 548-560. (Pubitemid 44066767)
40. ŚWI TKOWSKA-STODULSKA R, DEJNEKA W, OWCZARZAK A, DROBI SKA-JUROWIECKA A, KISZKIS H, WI NIEWSKI P, SWORCZAK K. Assessment of selected oxida-tive stress parameters in patients with Wilson's disease. Arch Med Sci 2009; 5: 465-470.
41. ZHANG LEI,CHEN LI-MEI,NI HONG-XIA,YU CHUN-RONG. Effects of puerarin on the expression of glucose transporter 4 in adipocytes of streptozocin in-duced diabetic rats. Chinese J Clin Rehabilit 2006; 10: 135-139.
42. GHOSH R, MUKHERJEE B, CHATTERJEE M. A novel effect of selenium streptozotocin-induced diabetic mice. Diabetes Res 1994; 25: 165-171.
43. MCNEILL JH, DELGATTY HLM, BATTELL ML. Insulin like effects of sodium selenate in streptozocin-induced diabetic rats. Diabetes 1991; 40: 1675-1678.
44. ERSÖZ G, YAKARYILMAZ A, TURAN B. Effect of sodium selenite treatment on platelet aggregation of streptozotocin-induced diabetic rats. Thromb Res 2003; 111: 363-367. (Pubitemid 38032903)
45. NAZiRO LU M, DILSIZ N, CAY M. Protective role of in-traperitoneally administered vitamins C and E and selenium on the levels of lipid peroxidation in lens of rats made diabetic with streptozotocin. Bi-ol Trace Elem Res 1999; 70: 223-322.
46. FÜRNSINN C, ENGLISCH R, EBNER K, NOWOTNY P, VOGL CLAUS,WALDHÄUSL W. Insulin-like vs non-insulin-like stimulation ofglucose metabolism by vanadium, tungsten, and selenium compounds in rat muscle. Life Sci 1998; 59: 1989-2000. (Pubitemid 26390200)
47. STAPLETON SR, GARLOCK GL, FOELLMI-ADAMS L, KLET-ZIEN R F. Selenium: potent stimulator of tyrosyl phosphorylation and activator of MAP kinase. Biochim Biophys Acta 1997; 1355: 259-269. (Pubitemid 27091382)
48. STAPLETON SR, JIVRAJ S, WAGLE A. Insulin and insulin-mimetic selenium mediate the regulation of glu-cose-6-phosphate dehydrogenase gene expression via difference signal proteins. FASEB J 1998; 12: 1404.